✦ LIBER ✦

MT-MMP expression in the development of human placenta

Book ID: 117315149
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 67 KB
Volume: 16
Category: Article
ISSN: 0143-4004
DOI: 10.1016/s0143-4004(05)80103-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of MT1-MMP and MMP2 expression

Analysis of MT1-MMP and MMP2 expression in human gastric cancers

✍ Masaki Mori; Koshi Mimori; Takeshi Shiraishi; Tatsuo Fujie; Kinya Baba; Hiroki K 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 217 KB 👁 2 views

## Membrane -type 1 matrix metalloproteinase (MT1-MMP) is a presumed activator of MMP2, which is one of the major proteinases in tumor cell invasion. In this study, we determined the clinico-pathologic significance of MT1-MMP expression in 68 human gastric carcinomas. The tumor-normal ratio (T/N r

Contrasting expression of membrane metal

Contrasting expression of membrane metalloproteinases, MT1-MMP and MT3-MMP, suggests distinct functions in skeletal development

✍ Maozhou Yang; Bingbing Zhang; Liang Zhang; Gary Gibson 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 676 KB

The role of MT4_MMP in renal development

✍ H. Colleta; M. Seiki; V. Quaranta; A. Pozzi; R. Zent 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

The role of MT1_MMP in renal development

✍ K.S. Riggins; G. Mernaugh; G. Moeckel; V. Quaranta; M. Seiki; N. Koshikawa; A. P 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Expression of a Progelatinase Activator

Expression of a Progelatinase Activator (MT1-MMP) in Human Fetal Membranes

✍ Stephen J. Fortunato; Ramkumar Menon; Salvatore J. Lombardi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

Vascular endothelial growth factor expre

Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas

✍ Carine Munaut; Agnès Noël; Olivier Hougrand; Jean-Michel Foidart; Jacques Bonive 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 340 KB 👁 1 views

Vascular endothelial growth factor (VEGF) is the major endothelial mitogen in central nervous system neoplasms and it is expressed in 64-95% of glioblastomas (GBMs). Tumour cells are the main source of VEGF in GBMs whereas VEGF receptors (VEGFR-1, its soluble form sVEGFR-1, VEGFR-2 and neuropilin-1)